NanoViricides, Inc. (NYSE American:NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

Alstom is celebrating the 150th anniversary of its Glasgow Traincare Centre, known as Polmadie Depot, with a public open day on 12 October—the ...

Regenxbio's RGX-121 gene therapy for Hunter syndrome is the main catalyst, with FDA approval targeted for February 2026.